LGALS3 Human (+)-schisandrin B multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:31150632 LGALS3 Human (1->4)-beta-D-glucan multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 LGALS3 Human 1,1-dichloroethene increases expression ISO Lgals3 (Mus musculus) 6480464 vinylidene chloride results in increased expression of LGALS3 mRNA CTD PMID:26682919 LGALS3 Human 1,4-dichlorobenzene increases expression ISO Lgals3 (Mus musculus) 6480464 4-dichlorobenzene results in increased expression of LGALS3 mRNA CTD PMID:26975756 LGALS3 Human 1-naphthyl isothiocyanate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA CTD PMID:17522070|PMID:25380136|PMID:30723492 LGALS3 Human 17alpha-ethynylestradiol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of LGALS3 mRNA CTD PMID:17557909 LGALS3 Human 17beta-estradiol affects expression ISO Lgals3 (Mus musculus) 6480464 Estradiol affects the expression of LGALS3 mRNA CTD PMID:15598610 LGALS3 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA; more ... CTD PMID:20660070|PMID:20823114 LGALS3 Human 17beta-estradiol increases expression ISO Lgals3 (Mus musculus) 6480464 Estradiol results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of more ... CTD PMID:38995820 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA CTD PMID:20159946 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:17035482|PMID:17337447|PMID:18796159|PMID:19933214|PMID:26290441 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:11489354|PMID:20106945|PMID:21632981|PMID:26238291 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:21570461|PMID:26377647|PMID:28922406 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:20959002|PMID:21215274|PMID:32109520|PMID:33387578 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:22298810|PMID:34747641 LGALS3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of LGALS3 mRNA CTD PMID:26705709 LGALS3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Lgals3 (Mus musculus) 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of LGALS3 mRNA CTD PMID:38648751 LGALS3 Human 2,6-dimethoxyphenol multiple interactions EXP 6480464 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the more ... CTD PMID:38598786 LGALS3 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 LGALS3 Human 2-nitrofluorene increases expression ISO Lgals3 (Rattus norvegicus) 6480464 2-nitrofluorene results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Lgals3 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LGALS3 mRNA CTD PMID:20959002 LGALS3 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LGALS3 mRNA CTD PMID:23196670 LGALS3 Human 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of LGALS3 protein CTD PMID:31675489 LGALS3 Human 3-chloropropane-1,2-diol decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA CTD PMID:28522335 LGALS3 Human 3-chloropropane-1,2-diol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of LGALS3 protein CTD PMID:34915118 LGALS3 Human 3-methylcholanthrene increases expression ISO Lgals3 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of LGALS3 mRNA CTD PMID:20713471 LGALS3 Human 3H-1,2-dithiole-3-thione decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in decreased expression of LGALS3 mRNA CTD PMID:19162173 LGALS3 Human 4,4'-diaminodiphenylmethane increases expression ISO Lgals3 (Rattus norvegicus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA CTD PMID:25380136 LGALS3 Human 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of LGALS3 mRNA CTD PMID:25912373 LGALS3 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of LGALS3 protein CTD PMID:34186270 LGALS3 Human 4,4'-sulfonyldiphenol decreases methylation ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in decreased methylation of LGALS3 exon CTD PMID:33297965 LGALS3 Human 4,4'-sulfonyldiphenol decreases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in decreased expression of LGALS3 mRNA CTD PMID:39298647 LGALS3 Human 4,4'-sulfonyldiphenol increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in increased expression of LGALS3 mRNA CTD PMID:30951980 LGALS3 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Lgals3 (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human 4-hydroxyphenyl retinamide decreases expression ISO Lgals3 (Mus musculus) 6480464 Fenretinide results in decreased expression of LGALS3 mRNA CTD PMID:28973697 LGALS3 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of LGALS3 mRNA CTD PMID:19194470 LGALS3 Human 5-fluorouracil affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 LGALS3 Human 5-fluorouracil multiple interactions ISO Lgals3 (Rattus norvegicus) 150530464 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD LGALS3 Human 5-fluorouracil decreases response to substance EXP 6480464 LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil CTD PMID:21750908 LGALS3 Human 6-propyl-2-thiouracil increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of LGALS3 mRNA CTD PMID:24780913 LGALS3 Human 7,12-dimethyltetraphene affects expression ISO Lgals3 (Mus musculus) 6480464 9,10-Dimethyl-1,2-benzanthracene affects the expression of LGALS3 mRNA CTD PMID:21785161 LGALS3 Human acetamide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 acetamide results in increased expression of LGALS3 mRNA CTD PMID:31881176 LGALS3 Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein; Dactinomycin inhibits the more ... CTD PMID:21821001|PMID:38460933 LGALS3 Human aflatoxin B1 increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:27153756 LGALS3 Human aflatoxin B1 decreases expression ISO Lgals3 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of LGALS3 mRNA CTD PMID:19770486 LGALS3 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:12875902 LGALS3 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LGALS3 mRNA CTD PMID:23724009 LGALS3 Human all-trans-retinoic acid decreases expression ISO Lgals3 (Mus musculus) 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:16604517 LGALS3 Human aluminium sulfate (anhydrous) multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Ovalbumin co-treated with aluminum sulfate] results in increased expression of LGALS3 protein; TLR2 protein affects more ... CTD PMID:38754639 LGALS3 Human ammonium chloride affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of LGALS3 mRNA CTD PMID:16483693 LGALS3 Human amphetamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of LGALS3 mRNA CTD PMID:30779732 LGALS3 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of LGALS3 protein CTD PMID:33212167 LGALS3 Human arsenite(3-) decreases expression ISO Lgals3 (Mus musculus) 6480464 arsenite results in decreased expression of LGALS3 protein CTD PMID:37955338 LGALS3 Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to LGALS3 protein]; arsenite promotes the reaction [G3BP1 more ... CTD PMID:32406909 LGALS3 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 LGALS3 Human benzo[a]pyrene increases expression ISO Lgals3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA CTD PMID:22228805|PMID:23735875 LGALS3 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of LGALS3 promoter CTD PMID:27901495 LGALS3 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of LGALS3 5' UTR CTD PMID:27901495 LGALS3 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA; Benzo(a)pyrene results in increased expression of LGALS3 more ... CTD PMID:16269432|PMID:18495319|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291 LGALS3 Human benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of LGALS3 mRNA CTD PMID:16269432 LGALS3 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of LGALS3 mRNA CTD PMID:38218311 LGALS3 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of LGALS3 mRNA CTD PMID:19737606 LGALS3 Human bexarotene decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 bexarotene results in decreased expression of LGALS3 mRNA CTD PMID:16648578 LGALS3 Human bezafibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Bezafibrate results in increased expression of LGALS3 mRNA CTD PMID:17118139 LGALS3 Human bis(2-chloroethyl) sulfide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Mustard Gas results in increased expression of LGALS3 protein CTD PMID:33002157 LGALS3 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of LGALS3 mRNA CTD PMID:31163220 LGALS3 Human bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 TFEB protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of LGALS3 protein] CTD PMID:38488668 LGALS3 Human bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of LGALS3 protein CTD PMID:38488668 LGALS3 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Lgals3 (Mus musculus) 6480464 TFEB protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of LGALS3 protein] CTD PMID:38488668 LGALS3 Human bis(2-ethylhexyl) phthalate decreases expression ISO Lgals3 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of LGALS3 protein CTD PMID:38488668 LGALS3 Human bisphenol A increases expression ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of LGALS3 mRNA CTD PMID:25181051 LGALS3 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LGALS3 protein CTD PMID:34186270 LGALS3 Human bisphenol A affects expression ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:32145629 LGALS3 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS3 protein CTD PMID:33376534|PMID:37567409 LGALS3 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:30903817 LGALS3 Human bisphenol A increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of LGALS3 gene CTD PMID:28505145 LGALS3 Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of LGALS3 protein CTD PMID:34186270 LGALS3 Human bisphenol F increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol F results in increased expression of LGALS3 mRNA CTD PMID:30951980 LGALS3 Human bleomycin A2 multiple interactions ISO Lgals3 (Mus musculus) 6480464 NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] CTD PMID:26526764 LGALS3 Human bleomycin A2 increases expression ISO Lgals3 (Mus musculus) 6480464 Bleomycin results in increased expression of LGALS3 protein CTD PMID:26526764 LGALS3 Human bucladesine multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 LGALS3 Human buspirone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Buspirone results in decreased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human cadmium dichloride affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of LGALS3 mRNA CTD PMID:22110744 LGALS3 Human cadmium dichloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of LGALS3 mRNA CTD PMID:25993096 LGALS3 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of LGALS3 mRNA CTD PMID:12875902 LGALS3 Human calyculin A increases expression ISO Lgals3 (Mus musculus) 6480464 calyculin A results in increased expression of LGALS3 mRNA CTD PMID:25270620 LGALS3 Human carbon nanotube affects expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes, Carbon affects the expression of LGALS3 mRNA CTD PMID:23845593 LGALS3 Human carbon nanotube increases expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes, Carbon analog results in increased expression of LGALS3 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681|PMID:27106021 LGALS3 Human cefaloridine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cephaloridine results in increased expression of LGALS3 mRNA CTD PMID:18500788 LGALS3 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to LGALS3 gene] CTD PMID:28238834 LGALS3 Human chloroform increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Chloroform results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human choline multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 LGALS3 Human ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA CTD PMID:16197558 LGALS3 Human cisplatin multiple interactions EXP 6480464 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein]; CAPN2 protein promotes more ... CTD PMID:21368866|PMID:21821001 LGALS3 Human cisplatin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [citrus pectin co-treated with Cisplatin] results in increased localization of LGALS3 protein CTD PMID:38522819 LGALS3 Human cisplatin decreases response to substance EXP 6480464 GAL3 protein results in decreased susceptibility to Cisplatin; LGALS3 protein mutant form results in decreased more ... CTD PMID:21368866|PMID:21750908|PMID:21821001 LGALS3 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of LGALS3 mRNA; Cisplatin results in increased expression of LGALS3 more ... CTD PMID:21821001|PMID:27392435 LGALS3 Human clofibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Clofibrate results in increased expression of LGALS3 mRNA CTD PMID:17585979 LGALS3 Human cobalt dichloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of LGALS3 mRNA CTD PMID:24386269 LGALS3 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of LGALS3 mRNA CTD PMID:19549813 LGALS3 Human Cuprizon increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of LGALS3 mRNA CTD PMID:26577399|PMID:27523638 LGALS3 Human cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 LGALS3 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of LGALS3 mRNA CTD PMID:25562108|PMID:27989131 LGALS3 Human cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of LGALS3 protein] CTD PMID:40023272 LGALS3 Human decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of LGALS3 protein CTD PMID:31675489 LGALS3 Human dexamethasone multiple interactions EXP 6480464 [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein CTD PMID:16166312 LGALS3 Human dexamethasone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 LGALS3 Human dibenz[a,h]anthracene increases expression EXP 6480464 1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA CTD PMID:16269432 LGALS3 Human dibenzo[a,l]pyrene increases expression EXP 6480464 dibenzo(a,l)pyrene results in increased expression of LGALS3 protein CTD PMID:18495319 LGALS3 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of LGALS3 mRNA CTD PMID:37042841 LGALS3 Human diclofenac increases expression ISO Lgals3 (Mus musculus) 6480464 Diclofenac results in increased expression of LGALS3 mRNA CTD PMID:26934552 LGALS3 Human dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of LGALS3 mRNA CTD PMID:28302478 LGALS3 Human diethylstilbestrol increases expression ISO Lgals3 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human diethylstilbestrol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human dimethylarsinic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of LGALS3 mRNA CTD PMID:16122865 LGALS3 Human dioxygen increases expression ISO Lgals3 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of LGALS3 mRNA CTD PMID:17193925 LGALS3 Human dioxygen multiple interactions ISO Lgals3 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA; [Oxygen more ... CTD PMID:19640911|PMID:30529165 LGALS3 Human dioxygen increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Oxygen deficiency results in increased expression of LGALS3 protein; Oxygen results in increased expression of more ... CTD PMID:22911455|PMID:32003113 LGALS3 Human diquat increases expression ISO Lgals3 (Mus musculus) 6480464 Diquat results in increased expression of LGALS3 mRNA CTD PMID:36851058 LGALS3 Human diuron increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diuron results in increased expression of LGALS3 mRNA CTD PMID:21551480 LGALS3 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 LGALS3 Human doxorubicin decreases response to substance EXP 6480464 LGALS3 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 LGALS3 Human doxorubicin increases expression ISO Lgals3 (Mus musculus) 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:36227756 LGALS3 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:29803840 LGALS3 Human endosulfan increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of LGALS3 mRNA CTD PMID:29391264 LGALS3 Human entinostat increases expression EXP 6480464 entinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 LGALS3 Human erythromycin estolate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Erythromycin Estolate results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human etoposide affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Etoposide CTD PMID:16217747 LGALS3 Human fenamidone increases expression ISO Lgals3 (Mus musculus) 6480464 fenamidone results in increased expression of LGALS3 mRNA CTD PMID:27029645 LGALS3 Human ferric oxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 ferric oxide analog results in increased expression of LGALS3 mRNA CTD PMID:38615722 LGALS3 Human flurbiprofen increases expression ISO Lgals3 (Mus musculus) 6480464 Flurbiprofen results in increased expression of LGALS3 mRNA CTD PMID:16949054 LGALS3 Human folic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Folic Acid results in increased expression of LGALS3 mRNA CTD PMID:10980121 LGALS3 Human folic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 LGALS3 Human furfural multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 LGALS3 Human genistein increases expression ISO Lgals3 (Mus musculus) 6480464 Genistein results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human gentamycin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of LGALS3 mRNA CTD PMID:33387578 LGALS3 Human glafenine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Glafenine results in increased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human GSK-J4 increases expression EXP 6480464 GSK-J4 results in increased expression of LGALS3 mRNA CTD PMID:29301935 LGALS3 Human hexadecanoic acid multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of LGALS3 protein] CTD PMID:40023272 LGALS3 Human hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of LGALS3 protein CTD PMID:40023272 LGALS3 Human isoprenaline increases expression ISO Lgals3 (Mus musculus) 6480464 Isoproterenol results in increased expression of LGALS3 mRNA CTD PMID:20003209 LGALS3 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of LGALS3 protein CTD PMID:32959892 LGALS3 Human L-ascorbic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ascorbic Acid results in increased expression of LGALS3 mRNA CTD PMID:15372504 LGALS3 Human L-methionine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 LGALS3 Human lactose affects binding EXP 6480464 Lactose binds to LGALS3 protein CTD PMID:17385862 LGALS3 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of LGALS3 mRNA CTD PMID:28988120|PMID:29427785 LGALS3 Human lipoteichoic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 TLR2 protein affects the reaction [lipoteichoic acid results in increased expression of LGALS3 protein] CTD PMID:38754639 LGALS3 Human lipoteichoic acid increases expression ISO Lgals3 (Mus musculus) 6480464 lipoteichoic acid results in increased expression of LGALS3 protein CTD PMID:38754639 LGALS3 Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein; 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits more ... CTD PMID:21821001 LGALS3 Human LY294002 decreases response to substance EXP 6480464 LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one CTD PMID:21821001 LGALS3 Human manganese(II) chloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of LGALS3 mRNA CTD PMID:28801915 LGALS3 Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 LGALS3 Human mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 LGALS3 Human methapyrilene increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human methimazole increases expression EXP 6480464 Methimazole results in increased expression of LGALS3 mRNA CTD PMID:20144635 LGALS3 Human methoxychlor increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 Methoxychlor results in increased methylation of LGALS3 gene CTD PMID:23303685 LGALS3 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of LGALS3 mRNA CTD PMID:23179753|PMID:34089799 LGALS3 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of LGALS3 mRNA CTD PMID:28001369 LGALS3 Human microcystin-LR increases expression ISO Lgals3 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of LGALS3 mRNA CTD PMID:17654400 LGALS3 Human mifepristone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Mifepristone results in decreased expression of LGALS3 mRNA CTD PMID:25972201 LGALS3 Human mitomycin C affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Mitomycin CTD PMID:16217747 LGALS3 Human monocrotaline multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased more ... CTD PMID:27870162 LGALS3 Human N,N-diethyl-m-toluamide multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 LGALS3 Human N-acetylsphingosine increases expression EXP 6480464 N-acetylsphingosine results in increased expression of LGALS3 protein CTD PMID:21821001 LGALS3 Human N-acetylsphingosine decreases response to substance EXP 6480464 LGALS3 results in decreased susceptibility to N-acetylsphingosine CTD PMID:21821001 LGALS3 Human N-acetylsphingosine multiple interactions EXP 6480464 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]; GSK3B mutant form more ... CTD PMID:21821001 LGALS3 Human N-ethyl-N-nitrosourea increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ethylnitrosourea results in increased expression of LGALS3 mRNA CTD PMID:15954086 LGALS3 Human N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 LGALS3 Human N-methyl-N-nitrosourea decreases expression ISO Lgals3 (Mus musculus) 6480464 Methylnitrosourea results in decreased expression of LGALS3 mRNA CTD PMID:25270620 LGALS3 Human N-methyl-N-nitrosourea increases expression ISO Lgals3 (Rattus norvegicus) 150530464 N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum RGD LGALS3 Human N-nitrosodiethylamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:19638242 LGALS3 Human N-nitrosodiethylamine multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 LGALS3 Human N-nitrosodiethylamine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA CTD PMID:24535843 LGALS3 Human N-nitrosodimethylamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:15890375|PMID:25380136 LGALS3 Human N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:17547211 LGALS3 Human N-nitrosomorpholine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of LGALS3 mRNA CTD PMID:19716841 LGALS3 Human naloxone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Naloxone results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human nickel atom increases expression ISO Lgals3 (Mus musculus) 6480464 Nickel results in increased expression of LGALS3 mRNA CTD PMID:12540486 LGALS3 Human nickel subsulfide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 nickel subsulfide results in increased expression of LGALS3 mRNA CTD PMID:21086188 LGALS3 Human nickel sulfate affects expression ISO Lgals3 (Mus musculus) 6480464 nickel sulfate affects the expression of LGALS3 mRNA CTD PMID:12718980 LGALS3 Human nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of LGALS3 mRNA CTD PMID:18651567 LGALS3 Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of LGALS3 mRNA CTD PMID:36318118 LGALS3 Human Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of LGALS3 protein CTD PMID:16054331 LGALS3 Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein CTD PMID:38460933 LGALS3 Human ochratoxin A increases expression ISO Lgals3 (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of LGALS3 mRNA CTD PMID:38301995 LGALS3 Human oxycodone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Oxycodone results in decreased expression of LGALS3 mRNA CTD PMID:23439660 LGALS3 Human ozone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ozone results in increased expression of LGALS3 protein CTD PMID:22727909 LGALS3 Human ozone multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... CTD PMID:34911549 LGALS3 Human panobinostat increases expression EXP 6480464 panobinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 LGALS3 Human paracetamol affects expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen affects the expression of LGALS3 mRNA CTD PMID:17562736 LGALS3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LGALS3 mRNA CTD PMID:26690555 LGALS3 Human paracetamol affects response to substance ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the susceptibility to Acetaminophen CTD PMID:22461450 LGALS3 Human paracetamol multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA]; LGALS3 protein more ... CTD PMID:22461450 LGALS3 Human paracetamol increases expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen results in increased expression of LGALS3 mRNA; Acetaminophen results in increased expression of LGALS3 more ... CTD PMID:22461450|PMID:34724096 LGALS3 Human paraquat increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Paraquat results in increased expression of LGALS3 mRNA; Paraquat results in increased expression of LGALS3 more ... CTD PMID:24521700|PMID:32680482 LGALS3 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 LGALS3 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of LGALS3 protein CTD PMID:26879310 LGALS3 Human permethrin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 LGALS3 Human phenacetin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Phenacetin results in increased expression of LGALS3 mRNA CTD PMID:17082564|PMID:17698508 LGALS3 Human phenobarbital multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA; NR1I3 protein affects the more ... CTD PMID:19482888|PMID:24535843 LGALS3 Human phenobarbital increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19162173 LGALS3 Human phenobarbital increases expression ISO Lgals3 (Mus musculus) 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19482888 LGALS3 Human phenylhydrazine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 phenylhydrazine results in increased expression of LGALS3 mRNA CTD PMID:17082564|PMID:17698508 LGALS3 Human phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 LGALS3 Human phorbol 13-acetate 12-myristate multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 LGALS3 Human phosgene affects expression ISO Lgals3 (Mus musculus) 6480464 Phosgene affects the expression of LGALS3 mRNA CTD PMID:16300373 LGALS3 Human piperonyl butoxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Piperonyl Butoxide results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 LGALS3 Human pirinixic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human pirinixic acid increases expression ISO Lgals3 (Mus musculus) 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:17118139 LGALS3 Human potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of LGALS3 protein CTD PMID:23718831 LGALS3 Human progesterone affects metabolic processing ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the metabolism of Progesterone CTD PMID:17242467 LGALS3 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 LGALS3 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of LGALS3 mRNA CTD PMID:21632981 LGALS3 Human quercetin multiple interactions ISO Lgals3 (Rattus norvegicus) 150530464 Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD LGALS3 Human quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of LGALS3 mRNA CTD PMID:21632981 LGALS3 Human quinoline increases expression EXP 6480464 quinoline analog results in increased expression of LGALS3 protein CTD PMID:18645022 LGALS3 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 LGALS3 Human reactive oxygen species increases abundance EXP 6480464 LGALS3 protein results in increased abundance of Reactive Oxygen Species CTD PMID:34894372 LGALS3 Human resveratrol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 resveratrol results in increased expression of LGALS3 mRNA CTD PMID:25905778 LGALS3 Human resveratrol multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA CTD PMID:25905778 LGALS3 Human rotenone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Rotenone results in increased expression of LGALS3 mRNA CTD PMID:27900601 LGALS3 Human S-(1,2-dichlorovinyl)-L-cysteine decreases expression EXP 6480464 S-(1,2-dichlorovinyl)cysteine results in decreased expression of LGALS3 mRNA CTD PMID:36336211|PMID:37544576 LGALS3 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 LGALS3 Human silicon atom multiple interactions EXP 6480464 [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 more ... CTD PMID:39353502 LGALS3 Human silicon atom multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 more ... CTD PMID:39353502 LGALS3 Human silicon dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA; Silicon Dioxide results in increased expression more ... CTD PMID:23221170|PMID:29341224|PMID:36223831 LGALS3 Human silicon dioxide multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 more ... CTD PMID:39353502 LGALS3 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LGALS3 protein CTD PMID:36223831 LGALS3 Human silicon dioxide multiple interactions EXP 6480464 [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 more ... CTD PMID:39353502 LGALS3 Human silicon dioxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA CTD PMID:21602193|PMID:22431001 LGALS3 Human sodium arsenite decreases expression ISO Lgals3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of LGALS3 protein CTD PMID:29044176 LGALS3 Human sodium chloride multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 LGALS3 Human sodium dichromate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of LGALS3 mRNA CTD PMID:25993096 LGALS3 Human sodium fluoride decreases expression ISO Lgals3 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of LGALS3 protein CTD PMID:28918527 LGALS3 Human streptozocin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA; vanadyl sulfate inhibits the more ... CTD PMID:16684804|PMID:25905778 LGALS3 Human streptozocin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of LGALS3 mRNA CTD PMID:16684804 LGALS3 Human sulindac multiple interactions EXP 6480464 Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] CTD PMID:15190207 LGALS3 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of LGALS3 mRNA CTD PMID:31533062 LGALS3 Human tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of LGALS3 mRNA CTD PMID:14699072 LGALS3 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of LGALS3 mRNA CTD PMID:31758290 LGALS3 Human testosterone increases expression ISO Lgals3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of LGALS3 mRNA CTD PMID:33848595 LGALS3 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of LGALS3 mRNA CTD PMID:33359661 LGALS3 Human tetrachloromethane increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA; Carbon Tetrachloride results in increased expression more ... CTD PMID:12629582|PMID:16549783|PMID:17522070|PMID:31150632 LGALS3 Human tetrachloromethane decreases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of LGALS3 protein CTD PMID:29044176 LGALS3 Human tetrachloromethane multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter]; schizandrin B inhibits the more ... CTD PMID:16309856|PMID:31150632 LGALS3 Human tetrachloromethane affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:12734012 LGALS3 Human tetrachloromethane multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 more ... CTD PMID:16549783|PMID:23798564 LGALS3 Human tetrachloromethane affects expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:17484886 LGALS3 Human tetrachloromethane increases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA; Carbon Tetrachloride results in increased expression more ... CTD PMID:16549783|PMID:23798564|PMID:31919559 LGALS3 Human tetracycline increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetracycline results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human theophylline increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Theophylline results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human thioacetamide multiple interactions ISO Lgals3 (Mus musculus) 6480464 MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] CTD PMID:23798564 LGALS3 Human thioacetamide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:34492290 LGALS3 Human thioacetamide multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 LGALS3 Human thioacetamide increases expression ISO Lgals3 (Mus musculus) 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:23798564 LGALS3 Human titanium dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 titanium dioxide results in increased expression of LGALS3 mRNA CTD PMID:23557971|PMID:27760801 LGALS3 Human titanium dioxide decreases methylation ISO Lgals3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of LGALS3 gene CTD PMID:35295148 LGALS3 Human tremolite asbestos increases expression ISO Lgals3 (Mus musculus) 6480464 tremolite results in increased expression of LGALS3 mRNA CTD PMID:29279043 LGALS3 Human trichloroethene increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 Trichloroethylene results in increased methylation of LGALS3 gene CTD PMID:27618143 LGALS3 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of LGALS3 mRNA CTD PMID:24935251|PMID:26272509 LGALS3 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 LGALS3 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of LGALS3 mRNA CTD PMID:30510588 LGALS3 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of LGALS3 mRNA CTD PMID:37042841 LGALS3 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA CTD PMID:29024780 LGALS3 Human tungsten decreases expression ISO Lgals3 (Mus musculus) 6480464 Tungsten results in decreased expression of LGALS3 mRNA CTD PMID:30912803 LGALS3 Human tunicamycin increases expression ISO Lgals3 (Mus musculus) 6480464 Tunicamycin results in increased expression of LGALS3 mRNA CTD PMID:17127020 LGALS3 Human valdecoxib increases expression ISO Lgals3 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human valproic acid affects expression ISO Lgals3 (Mus musculus) 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:17963808 LGALS3 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 LGALS3 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of LGALS3 mRNA CTD PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369 LGALS3 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:25979313 LGALS3 Human vanadyl sulfate multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 LGALS3 Human vancomycin decreases expression ISO Lgals3 (Mus musculus) 6480464 Vancomycin results in decreased expression of LGALS3 mRNA CTD PMID:18930951 LGALS3 Human vinclozolin affects expression ISO Lgals3 (Rattus norvegicus) 6480464 vinclozolin affects the expression of LGALS3 mRNA CTD PMID:19015723 LGALS3 Human vinclozolin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of LGALS3 mRNA CTD PMID:23034163 LGALS3 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 LGALS3 Human zinc oxide decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Zinc Oxide results in decreased expression of LGALS3 protein CTD PMID:33205376
